🟢 Medpace Holdings is trading 4.42% up today amid a 2.12% healthcare-sector gain

Medpace Holdings is trading at $649.97, up 4.42%, amid healthcare-sector strength; the sector is up 2.12% during the regular session.

• Investors are also focused on Medpace Holdings’ Q3 2026 results, scheduled for after the market close on October 21.
• Ahead of the report, analyst consensus cited about $714.5 million in revenue and $4.44 EPS.
• No company-specific announcement explaining the intraday gain was identified.